StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
PTPI

Petros Pharmaceuticals, Inc.

PTPI OTC Pharmaceutical Preparations EDGAR ↗
$0.00
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$127K
Revenue (TTM)
$5.11M
Net income (TTM)
$3.19M
EPS (TTM)
$7.78
P/E ratio
0.0
Dividend yield
Free cash flow
-$6.76M
Cash
$4.35M
Total assets
$4.39M
Gross margin
76.3%
52-week range
$0.00 – $0.03

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change Jun 18, 2026 8-K Director or officer change Jun 5, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 8-K Director or officer change Jan 2, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Delisting notice or listing-rule failure Nov 7, 2025 8-K Changed accountants Sep 5, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Regulation FD disclosure Jun 20, 2025 8-K Delisting notice or listing-rule failure May 21, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Delisting notice or listing-rule failure; Modified rights of security holders; Amended charter or bylaws May 2, 2025 8-K Delisting notice or listing-rule failure; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Shareholder vote results Apr 11, 2025 8-K Changed accountants Apr 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Entered a material agreement; Other events Feb 21, 2025 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws Jan 24, 2025 8-K Triggering event accelerating an obligation Dec 16, 2024 8-K Shareholder vote results Nov 21, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Director or officer change Oct 18, 2024 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws Oct 17, 2024 8-K Director or officer change Oct 4, 2024 8-K Item 5.08 Sep 19, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 10-K/A Fiscal year ended 2023-12-31 May 31, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024 8-K Entered a material agreement Mar 22, 2024 8-K Changed accountants Jan 12, 2024 8-K Shareholder vote results Dec 29, 2023 8-K Director or officer change Dec 28, 2023 10-Q Quarter ended 2023-09-30 Nov 15, 2023 8-K Amended charter or bylaws Oct 2, 2023 8-K Modified rights of security holders; Director or officer change; Amended charter or bylaws; Shareholder vote results Sep 15, 2023 8-K Amended charter or bylaws Aug 15, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events Jul 13, 2023 10-Q Quarter ended 2023-03-31 May 15, 2023